Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by JayjayUSA12007on Feb 09, 2020 2:33am

109 Views

Post# 30663596

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Theratechnologies hires Grinspoon for tesamorelin study

Luc (paraphrased): "...They already met with the FDA and were waiting for an answer of them (he
said literally "with the FDA you are never sure of the timeline, therefore the
end of 1 H mention). They were waiting for an answer and were confident
they could answer every possible question from the FDA"

Dubuc (paraphrased):
"...We never announced that the meeting had taken place or the date of that meeting, the only timeframe we discussed is that we would report on the outcome before the end of the first half of 2020..."

Dubuc clearly did not denied that the meeting already took place, but he neither confirmed it.
This is typical talk ! "Neither confirm, nor deny" kind of things....
Luc's answer is more likely true, for he specifically confirmed it.

Bullboard Posts

Eminent acquires promising Nevada gold project